OncoArendi Therapeutics is a biotech company focused on discovery and development of small molecule drug candidates. It studies the therapeutic potential of chitinases and chitinase-like-proteins (CLPs) in diverse inflammatory and fibrotic diseases. The company develops OATD-01 (a therapy for multiple lung diseases), YKL-40 (a glioblastoma multiforme therapy for cancers), and more.